Seoul, South Korea

So Ra Paik

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: So Ra Paik and His Groundbreaking Patent on Anti-inflammatory Compounds

Introduction: So Ra Paik, an innovative inventor based in Seoul, South Korea, has made significant strides in the field of pharmaceuticals with his notable patent. His research and development efforts focus on creating compounds that can effectively address inflammatory diseases, contributing valuable insights to the medical community.

Latest Patents: Paik holds a patent for his invention titled "Anti-inflammatory 6-phenoxypyrimidine derivatives, process for their preparation and pharmaceutical composition containing them." This innovative patent pertains to a 6-phenoxypyrimidine derivative that has demonstrated the ability to inhibit the production of nitric oxide (NO), a key factor in inflammation. The compound presents a promising solution for treating and preventing various inflammatory diseases, including immunological disorders.

Career Highlights: So Ra Paik is currently associated with the Korea Institute of Science and Technology, where he harnesses his expertise to explore advancements in pharmaceutical compositions and their applications. His work is characterized by a strong commitment to addressing complex health challenges through scientific innovation.

Collaborations: Throughout his career, Paik has collaborated with esteemed colleagues, including Eun Joo Roh and Karam Mohamed Hasan Fara Ahmed. These collaborations have enriched his research and aided in the development of innovative therapeutics designed to improve patient outcomes.

Conclusion: So Ra Paik stands out as a leading inventor in the field of pharmaceutical sciences, particularly with his focused approach towards creating anti-inflammatory compounds. His contributions signify an essential step forward in treating inflammatory diseases, fostering hope for future therapies that may arise from his work.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…